Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2018
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic AnalysisDaniel J George, Jean-Francois Martini, Michael Staehler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
Internalization of oncolytic reovirus by human dendritic cell carriers protects the virus from neutralizationElizabeth J Ilett, Montserrat Bárcena, Fiona Errington-Mais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Tumor infection by oncolytic reovirus primes adaptive antitumor immunityRobin J Prestwich, Fiona Errington, Elizabeth J Ilett, et al.
BMC Cancer|August 28, 2012
Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathwayKatie Twigger, Victoria Roulstone, Joan Kyula, et al.
BJU International|February 6, 2021
Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinibGuillermo de Velasco, Álvaro Ruiz-Granados, Oscar Reig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2019
Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder CancerNicola E Annels, David Mansfield, Mehreen Arif, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2010
Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancersKevin J Harrington, Eleni M Karapanagiotou, Victoria Roulstone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignanciesEleni M Karapanagiotou, Victoria Roulstone, Katie Twigger, et al.
European Urology|October 3, 2017
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival ResultsRobert J Motzer, Alain Ravaud, Jean-Jacques Patard, et al.
Science Translational Medicine|January 26, 2018
Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissuesAadil A Khan, James T Paget, Martin McLaughlin, et al.
Pageof 7